Only 6 of these miRNAs were shared as differentially enriched biomarkers between the HER2+ and CD24+ EVs, suggesting that these EV subpopulations represent complementary biomarkers for the classification of BI-RADS 4 breast lesions. Here, ERBB2 is linked to neoplasm.